Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia – Full Text View – ClinicalTrials.gov

Posted on June 19, 2019 by Maurice Preter MD

Of note, >>[p]atients with orthostatic hypotension, ulcerative colitis, hyperthyroidism, dementia or cognitive dysfunction, Parkinson’s disease, or cerebrovascular disorder<< were excluded. How many real-life patients with BPH also have one of the above?

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia – Full Text View – ClinicalTrials.gov.

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

This study has been completed.
Sponsor:
Information provided by:
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00771394
First received: October 9, 2008
Last updated: March 3, 2010
Last verified: March 2010
History of Changes